Medtech finds AI applications
Artificial intelligence is making its mark in medical technology applications.
Investing. Plain and simple.
Artificial intelligence is making its mark in medical technology applications.
Its 5th generation da Vinci robotic surgery tool has 10,000 times more processing power that generation 4.
Lilly has more than doubled in a year, while Denmark’s Novo Nordisk is up by two-thirds.
Elil Lilly and Novo Nordisk have head start on market projected to hit $100B in US by 2030.
Strong demand for Wegovy, Ozempic just scratching surface, says CEO of Novo Nordisk
Shipping costs and chip shortages have eased as demand for elective surgeries has recovered
Celebrity endorsements helping build market potential, analysts say
Slowing growth in core businesses, plus recalls and bribery allegation have worried investors
Telehealth services remain popular but billing and regulatory challenges are slowing its growth.
Demand for boosters falls as virus seen as something less to be feared than managed
You must be logged in to post a comment.